BioGend is a company based in Taipei, Taiwan, that specializes in orthopedic and regenerative medicine products. One of our main innovations is RevoCart, a technology that can harvest, process, and implant autologous cartilage cells in a single surgery. Another breakthrough is SoufCut, a technology that can slice soft tissues that are hard to handle and obtain valuable SVF to fill under the skin. These are our two core technologies. BioGend not only has its own ISO7 facility to produce its own products, but also offers OEM services to external partners, delivering high-quality design and manufacturing to the whole world.
Company Details
- Employees
- 11
- Founded
- -
- Address
- 3-2 Park Street, 4 Floor,taiwan, Province Of China
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- https://www.biogend.com.tw/
- Keywords
- to external partners.
- HQ
- Nangang District, Taipei City
Biogend Therapeutics (Twse 6733) Questions
Biogend Therapeutics (Twse 6733)'s website is https://www.biogend.com.tw/
Biogend Therapeutics (Twse 6733)'s LinkedIn profile is https://tw.linkedin.com/company/biogend-therapeutics
Biogend Therapeutics (Twse 6733) has
11 employees.
View email and phone details for 11
employees at Biogend Therapeutics (Twse 6733).
Biogend Therapeutics (Twse 6733)'s industry is
Medical Equipment Manufacturing
Biogend Therapeutics (Twse 6733)'s top competitors are
Medpace,
Optima Packaging Group,
Thermo Fisher Scientific,
Braxx Biotech Co., Ltd.,
Nova Medical Corporation Ltd,
Ima Taipei Chapter,
Mycenax Biotech Inc.,
Benq Dialysis Technology Corp,
晟德（two：4123）center Ventures,
Pfizer.
Biogend Therapeutics (Twse 6733)'s categories are Medical Equipment Manufacturing
Biogend Therapeutics (Twse 6733)'s founding year is 2016
